Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07042945
PHASE1

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

This study will examine if at least one dose level of MK-4646 can lower HIV-1 viral load in a person's blood by a certain amount. The goals of this study are to learn about the safety of MK-4646 and if people tolerate it; and how HIV-1 viral load may decrease after starting to take MK-4646.

Official title: Multiple Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of MK-4646 Monotherapy in Antiretroviral Therapy-Naïve Participants With HIV-1

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

28

Start Date

2025-07-09

Completion Date

2026-06-22

Last Updated

2026-03-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

MK-4646

MK-4646 in capsular form administered orally

Locations (2)

PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 0002)

Chisinau, Moldova

ARENSIA Exploratory Medicine ( Site 0001)

Bucharest, București, Romania